PA Winstanley

Mutations in<i>Plasmodium falciparum</i>Dihydrofolate Reductase and Dihydropteroate Synthase and Epidemiologic Patterns of Pyrimethamine‐Sulfadoxine Use and Resistance

Christopher V. Plowe, J F Cortese, Abdoulaye Djimdé et al. · The Journal of Infectious Diseases · 1997 · 416 citations · Full text

Aldo-keto Reductase, Genetics, Malaria +18

Intracranial hypertension in Africans with cerebral malaria

Charles R. Newton, Jane Crawley, A Sowumni et al. · Archives of Disease in Childhood · 1997 · 196 citations · Full text

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

W.M. Watkins, E.K. Mberu, PA Winstanley et al. · Parasitology Today · 1997 · 155 citations

Predictive Model, Pharmacological Study, Antiparasitic Agent +10

Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial

Ali Alloueche, W. S. Bailey, Sarah Barton et al. · The Lancet · 2004 · 107 citations

Uncomplicated Falciparum Malaria, Medicine, Antiparasitic Agent +4

Kenyan <i>Plasmodium falciparum</i> Field Isolates: Correlation between Pyrimethamine and Chlorcycloguanil Activity In Vitro and Point Mutations in the Dihydrofolate Reductase Domain

A Nzila-Mounda, E.K. Mberu, Carol Hopkins Sibley et al. · Antimicrobial Agents and Chemotherapy · 1998 · 104 citations · Full text